NOT KNOWN DETAILS ABOUT PSYCHEDELICS IN THE NEWS

COMPASS Pathways, a mental health treatment business, received the designation for its psilocybin therapy for treatment-resistant depression in 2018. In 2019, Usona Institute, a nonprofit health-related researcher, gained the designation to continue its tests of psilocybin as being a treatment for big depressive disorder.As well as different health